Latest News

Pressat

As cannabis makes its way into the mainstream across Europe, the continent’s premium B2B cannabis industry conference – Cannabis Europa – takes place at London’s Old Billingsgate on 28-29 June, supported by leading businesses in this rapidly growing space.

Talk Markets

2022 started with an incredible amount of progress and hope with European cannabis fast becoming a hot emerging market. Just like the United States’ state-by-state movement, Europe is moving country-by-country toward providing access to cannabis. The best way to highlight the progress in the first quarter is to look at three markers: Merger and acquisition (M&A) activity, progress in the medical markets in the top eight European countries, and current legislative pushes for adult-use cannabis.

U.S. News

Both strides and setbacks have punctuated the quest for federal legalization of cannabis in the U.S. So far, 38 states have legalized marijuana for medical use. The recreational use of marijuana is legal in 19 states plus the District of Columbia and Guam, and the U.S. House of Representatives in April passed legislation to legalize marijuana at the federal level for the second time in less than two years.

Cannabis Law Journal

Now that your GMP facility has been opened, it’s time to add some new products to your new facility. Luckily, your facility is already GMP-certified, so adding new products is much easier than when you were initially qualifying the facility. Whether it be adding or repurposing rooms, ordering new equipment and procedures, the process will be smoother with certification.

Prohibition Partners

What is SOMAÍ Pharmaceuticals?
SOMAÍ Pharmaceuticals Ltd is a European pharmaceutical and
biotech company with a manufacturing centre in Lisbon

Technical 420

As global stress and market uncertainties remain high during the Russian invasion of Ukraine, investors looking for stability in times of turbulence are turning to sin stocks for their tendency to outperform the broader averages in times of market downturn.

Cannabis Wealth

Inflation is at a record high, but cannabis prices are continuing to fall.
Could cannabis be inflation-proof or are there other factors keeping cannabis prices down? Cannabis Wealth spoke to economist and cannabis expert Andrew Livingston from the US cannabis law firm Vicente Sederberg to find out.

Drug Target Review

Michael Sassano and Anthony DeMeo from Somai Pharmaceuticals discuss using ethosomes as an improved method to deliver cannabinoids to the human body.

MJBizDaily

Last year proved to be an interesting one for the entire cannabis industry.

In particular, the emergence of large pharmaceutical companies entering the space has returned attention to medical cannabis and brought it out from under the shadow of the adult-use market.